Quick Takeaways
- SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A for Abeona Therapeutics Inc. Common Stock, $0.01 par value (ABEO).
- Disclosed ownership: 5.2%.
- Date of event: 30 Jun 2025.
SUVRETTA CAPITAL MANAGEMENT, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Abeona Therapeutics Inc. Common Stock, $0.01 par value (ABEO)
- Filing Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Reporting Manager
- Suvretta Capital Management, LLC
- Symbol
- ABEO
- Shares outstanding
- 51,461,538 shares
- Disclosed Ownership
- 2,676,000 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Aug 2025, 19:53:25 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 5.2% ownership in Abeona Therapeutics Inc. Common Stock, $0.01 par value (ABEO) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 19:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 5.2% | 2,676,000 | 0 | 2,676,000 | /s/ Andrew Nathanson | Andrew Nathanson/General Counsel and Chief Compliance Officer | |
| Averill Master Fund, Ltd. | 4.5% | 2,309,267 | 0 | 2,309,267 | /s/ Andrew Nathanson | Andrew Nathanson/Authorized Signatory | |
| Aaron Cowen | 5.2% | 2,676,000 | 0 | 2,676,000 | /s/ Aaron Cowen | Aaron Cowen |